Group 1 - The core point of the article highlights that southbound funds have increased their holdings in Chunli Medical (01858.HK) by 168,200 shares on February 27, with a total net increase of 152,000 shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have reduced their holdings in Chunli Medical for 12 days, resulting in a cumulative net reduction of 1,129,700 shares [1] - As of now, southbound funds hold 41,216,800 shares of Chunli Medical, accounting for 43.31% of the company's total issued ordinary shares [1] Group 2 - Chunli Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices in China [1] - The company's main products include joint prosthetics, spinal implants, trauma products, sports medicine products, platelet-rich plasma (PRP) products, oral products, and surgical robots [1] - The joint prosthetics product line covers four major human joints: hip, knee, shoulder, and elbow, with products sold in both domestic and international markets [1]

Core Viewpoint - Southbound funds increased their holdings in Chuangli Medical (01858.HK) by 61,000 shares on February 13, 2023, despite a net reduction of 338,800 shares over the past five trading days [1] Group 1: Southbound Fund Activity - In the last five trading days, there were three days of net reductions in holdings by southbound funds, totaling 338,800 shares [1] - Over the past 20 trading days, there were ten days of net reductions, amounting to 246,800 shares [1] - As of now, southbound funds hold 41,125,800 shares of Chuangli Medical, representing 43.21% of the company's issued ordinary shares [1] Group 2: Company Overview - Beijing Chuangli Zhengda Medical Device Co., Ltd. primarily engages in the research, development, production, and sales of implantable orthopedic medical devices [1] - The company's main products include joint prosthetics, spinal implants, trauma products, sports medicine products, platelet-rich plasma (PRP) products, oral products, and surgical robots [1] - Joint prosthetics cover four major human joints: hip, knee, shoulder, and elbow, with products sold in both domestic and international markets [1]

Core Viewpoint - Southbound funds increased their holdings in Chuangli Medical (01858.HK) by 12,700 shares on February 9, indicating a fluctuating interest from these investors in the company [1] Group 1: Southbound Fund Activity - Over the past five trading days, there were three days of net reductions in holdings by southbound funds, totaling a net decrease of 674,000 shares [1] - In the last twenty trading days, there were ten days of net reductions, with a cumulative net decrease of 769,000 shares [1] - Currently, southbound funds hold 41,477,300 shares of Chuangli Medical, accounting for 43.59% of the company's total issued ordinary shares [1] Group 2: Company Overview - Beijing Chuangli Zhengda Medical Device Co., Ltd. specializes in the research, development, production, and sales of implantable orthopedic medical devices [1] - The company's main products include joint prosthetics, spinal implants, trauma products, sports medicine products, platelet-rich plasma (PRP) products, oral products, and surgical robots [1] - Joint prosthetics cover four major human joints: hip, knee, shoulder, and elbow, with products sold in both domestic and international markets [1]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Spring Medical (01858.HK) by 153,800 shares on February 5, 2026, marking a decrease of 0.37% [1][2] - Over the past five trading days, there have been three days of net reductions by southbound funds, totaling 427,300 shares [1] - In the last twenty trading days, there were eleven days of net reductions, amounting to 2,033,000 shares [1] Group 2 - As of now, southbound funds hold 41,678,300 shares of Spring Medical, which represents 43.79% of the company's total issued ordinary shares [1] - Spring Medical is primarily engaged in the research, development, production, and sales of implantable orthopedic medical devices, including joint prosthetics, spinal implants, trauma products, sports medicine products, platelet-rich plasma (PRP) products, oral products, and surgical robots [2] - The company's joint prosthetic products cover major human joints such as the hip, knee, shoulder, and elbow, and its products are sold in both domestic and international markets [2]

Group 1 - The core point of the article highlights the recent trading activity of southbound funds in Spring Medical (01858.HK), indicating a net reduction in holdings over the past trading days [1] - On February 2, 2026, southbound funds increased their holdings by 74,000 shares, marking a 0.18% increase [2] - Over the last five trading days, there were four days of net reductions, totaling a decrease of 405,800 shares [1][2] - In the last 20 trading days, there were 11 days of net reductions, with a cumulative decrease of 3,113,500 shares [1] Group 2 - As of February 2, 2026, southbound funds hold a total of 42,151,300 shares of Spring Medical, which represents 44.29% of the company's issued ordinary shares [1] - Spring Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics, spinal implants, trauma products, sports medicine products, PRP products, oral products, and surgical robots [2] - The company's joint prosthetic products cover major human joints such as hip, knee, shoulder, and elbow, and are sold in both domestic and international markets [2]

Core Insights - Southbound funds increased their holdings in Chuangli Medical (01858.HK) by 21,200 shares on January 23 [1] - Over the past five trading days, there have been five days of net increases in holdings, totaling 995,300 shares [1] - In the last twenty trading days, there were eight days of net reductions, amounting to 2,141,500 shares [1] - Currently, southbound funds hold 42,367,800 shares of Chuangli Medical, representing 44.52% of the company's issued ordinary shares [1] Company Overview - Beijing Chuangli Zhengda Medical Device Co., Ltd. primarily engages in the research, development, production, and sales of implantable orthopedic medical devices [1] - The company's main products include joint prosthetics, spinal implants, trauma products, sports medicine products, platelet-rich plasma (PRP) products, oral products, and surgical robots [1] - Joint prosthetics cover four major human joints: hip, knee, shoulder, and elbow [1] - The company's products are sold in both domestic and international markets [1]

Group 1 - The core viewpoint of the article highlights the recent increase in southbound capital holdings in Chunli Medical (01858.HK), with a net increase of 113,800 shares on January 22 [1] - Over the past five trading days, Chunli Medical has seen an increase in southbound capital for four days, totaling a net increase of 865,300 shares [1] - In the last twenty trading days, there were eight days of net reduction in southbound capital, amounting to a total decrease of 1,949,000 shares [1] Group 2 - As of now, southbound capital holds 42,346,600 shares of Chunli Medical, representing 44.5% of the company's total issued ordinary shares [1] - Chunli Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices, with key products including joint prosthetics, spinal implants, trauma products, sports medicine products, PRP products, oral products, and surgical robots [1] - The company's joint prosthetic products cover major human joints such as hip, knee, shoulder, and elbow, and its products are sold in both domestic and international markets [1]

Group 1 - The core viewpoint of the article highlights the recent trading activity of southbound funds in Spring Medical (01858.HK), indicating a mixed trend with both increases and decreases in holdings [1] - Southbound funds increased their holdings by 368,800 shares on January 19, while over the past five trading days, there were three days of net reductions totaling 505,000 shares [1] - Over the last 20 trading days, there were ten days of net reductions, amounting to a total of 2,725,500 shares [1] Group 2 - As of now, southbound funds hold 41,741,300 shares of Spring Medical, which represents 43.86% of the company's total issued ordinary shares [1] - Spring Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices, with key products including joint prosthetics, spinal implants, trauma products, sports medicine products, PRP products, oral products, and surgical robots [1] - The company's joint prosthetic products cover major human joints such as hip, knee, shoulder, and elbow, and its products are sold in both domestic and international markets [1]